PO004LBA/#1515  Efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer following prior systemic therapy

التفاصيل البيبلوغرافية
العنوان: PO004LBA/#1515  Efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer following prior systemic therapy
المؤلفون: Grisham, Rachel, Aghajanian, Carol, Nieuwenhuysen, Els Van, Rodrigues, Manuel, Ring, Kari, Santin, Alessandro, Colombo, Nicoletta, Prendergast, Emily, Thaker, Premal, Moore, Kathleen, Salinas, Erin, Ray-Coquard, Isabelle, Chon, Hye Sook, Rose, Peter, Oaknin, Ana, Clamp, Andrew, Gandhi, Mitul, Monk, Bradley, Holloway, Robert, Gorp, Toon Van, Fabbro, Michel, Gennigens, Christine, Wojtynek, Nicholas, Lustgarten, Stephanie, Banerjee, Susana
المصدر: International Journal of Gynecological Cancer (2023-11); IGCS 2023, Seoul, South Korea [KR], 5-7 November 2023
بيانات النشر: BMJ Publishing Group Ltd, 2023.
سنة النشر: 2023
مصطلحات موضوعية: Human health sciences, Oncology, Sciences de la santé humaine, Oncologie
نوع الوثيقة: conference paper
http://purl.org/coar/resource_type/c_5794
conferenceObject
peer reviewed
اللغة: English
Relation: https://syndication.highwire.org/content/doi/10.1136/ijgc-2023-IGCS.4; urn:issn:1048-891X; urn:issn:1525-1438
DOI: 10.1136/ijgc-2023-igcs.4
URL الوصول: https://orbi.uliege.be/handle/2268/311324
حقوق: restricted access
http://purl.org/coar/access_right/c_16ec
info:eu-repo/semantics/restrictedAccess
رقم الأكسشن: edsorb.311324
قاعدة البيانات: ORBi
الوصف
DOI:10.1136/ijgc-2023-igcs.4